IDH1 Non-Canonical Mutations and Survival in Patients with Glioma

Background: Non-canonical mutations of the isocitrate dehydrogenase (IDH) genes have been described in about 20–25% and 5–12% of patients with WHO grade II and III gliomas, respectively. To date, the prognostic value of these rare mutations is still a topic of debate. Methods: We selected patients w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diagnostics (Basel)
Hlavní autoři: Franceschi, Enrico, De Biase, Dario, Di Nunno, Vincenzo, Pession, Annalisa, Tosoni, Alicia, Gatto, Lidia, Tallini, Giovanni, Visani, Michela, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7922632/
https://ncbi.nlm.nih.gov/pubmed/33669525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11020342
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky